Jacobs Levy Equity Management, Inc Pulmonx Corp Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 260,418 shares of LUNG stock, worth $414,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260,418Holding current value
$414,064% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding LUNG
# of Institutions
121Shares Held
33.9MCall Options Held
0Put Options Held
12K-
Primecap Management CO Pasadena, CA5.16MShares$8.21 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$5.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.65 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$3.01 Million0.11% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $59.3M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...